World Health Organization site
Skip Navigation Links

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Last refreshed on: 19 October 2017
Main ID:  NCT00724243
Date of registration: 25/07/2008
Prospective Registration: No
Primary sponsor: Merck Sharp & Dohme Corp.
Public title: Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)
Scientific title: Remicade Treatment Registry in Rheumatoid Arthritis I
Date of first enrolment: January 2006
Target sample size: 33
Recruitment status: Completed
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
Key inclusion & exclusion criteria

Inclusion Criteria:

- Subject must have been given patient leaflet,

- Subject must not have ever received infliximab at the time of registration,

- Subject must be a good candidate for infliximab as per Summary of Product

- Subject must sign the approved consent form

Exclusion Criteria:

Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Rheumatoid Arthritis
Drug: Infliximab
Primary Outcome(s)
Average Change in Disease Activity Score 28 (DAS 28) From the Beginning of the Treatment [Time Frame: Baseline, Week 14, and Week 54]
Number of Participants Fulfilling Criteria for a Therapeutic Response According to the European League Against Rheumatism (EULAR) Response Criteria [Time Frame: Week 14 and Week 54]
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results available: Yes
Date Posted: 19/02/2010
Date Completed:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history